{"id":1327,"date":"2019-11-05T23:28:10","date_gmt":"2019-11-05T23:28:10","guid":{"rendered":"http:\/\/www.trendsandtargets.com\/?p=1327"},"modified":"2019-11-06T13:13:41","modified_gmt":"2019-11-06T13:13:41","slug":"faron-pharma-for-6-11-2019","status":"publish","type":"post","link":"http:\/\/www.trendsandtargets.com\/index.php\/2019\/11\/05\/faron-pharma-for-6-11-2019\/","title":{"rendered":"Faron Pharma. for 6\/11\/2019"},"content":{"rendered":"\n

#BRENT #NASDAQ <\/strong>When we last reviewed Faron, we promoted a scenario for a 25% rise (link). The move successfully happened in May and in the period since, it has more than doubled! Thankfully someone emailed to remind us this was urgently due a Big Picture update.<\/p>\n\n\n\n

This one is extremely difficult to map thanks to a \nbunch of quite separate calculations. When we now refresh our numbers, the share \nprice has quite several distinct formula, all pointing at a high of 276p. The \nother day, it bettered this level, achieving 277.5p. It has created the \nsituation where we should anticipate price movement now exceeding 258p to \nprovoke yet another surge, this time in the direction of 319p.<\/p>\n\n\n\n

Above 319p and things get a bit vague but we can \ncalculate a high of 392p and no further. Unless, of course, if goes higher and \nin which case, we shall need review the tea leaves again!<\/p>\n\n\n\n

The price certainly received an absolute hammering, \nonce it hit the 277 level. Reversing to 150p within the same session really was \nnot fair and now, has created the situation where weakness below 180p threatens \nreversal to 130p initially. If broken, secondary calculates at 81p. We’re not \nconvinced it is on the edge of doom, instead suspecting whatever drove the \namazing rise has seen some sanity enter the conversation.<\/p>\n\n\n\n

Regardless, by any standards, we’re fairly optimistic \nfor this lots longer term future and dreading, once again, how to handle things \nif it indeed approaches the 4 quid level.<\/p>\n\n\n\n

\"\"\/<\/figure>\n\n\n\n<\/p>\n\n\n
\n\t

Time Issued<\/font><\/TD>

\n\t

Market<\/font><\/TD>

\n\t

Price At Issue<\/font><\/TD>

\n\t

Short Entry<\/font><\/TD>

\n\t

Fast Exit<\/font><\/TD>

\n\t

Slow Exit<\/font><\/TD>

\n\t

Stop<\/font><\/TD>

\n\t

Long Entry<\/font><\/TD>

\n\t

Fast Exit<\/font><\/TD>

\n\t

Slow Exit<\/font><\/TD>

\n\t

Stop<\/font><\/TD>

\n\t

Prior<\/font><\/TD> <\/TR>\nFUTURES<\/font><\/a>

\n\t

9:46:29PM<\/font><\/TD>

\n\t

BRENT<\/font><\/TD>

\n\t

62.77<\/font><\/TD>

\n\t

61.86<\/font><\/TD>

\n\t

61.47<\/font><\/TD>

\n\t

60.95<\/font><\/TD>

\n\t

62.78<\/font><\/TD>

\n\t

62.97<\/font><\/TD>

\n\t

63.13<\/font><\/TD>

\n\t

63.59<\/font><\/TD>

\n\t

62.47<\/font><\/TD>

\n\t

‘cess<\/font><\/TD> <\/TR>\n

\n\t

9:49:39PM<\/font><\/TD>

\n\t

GOLD<\/font><\/TD>

\n\t

1484.27<\/font><\/TD>

 <\/TD>  <\/TD>  <\/TD>  <\/TD>  <\/TD>  <\/TD>  <\/TD>  <\/TD> \n\t

Success<\/font><\/TD> <\/TR>\n

\n\t

9:51:27PM<\/font><\/TD>

\n\t

FTSE<\/font><\/TD>

\n\t

7380.55<\/font><\/TD>

 <\/TD>  <\/TD>  <\/TD>  <\/TD>  <\/TD>  <\/TD>  <\/TD>  <\/TD> \n\t

<\/TD> <\/TR>\n

\n\t

9:54:06PM<\/font><\/TD>

\n\t

FRANCE<\/font><\/TD>

\n\t

5847.9<\/font><\/TD>

 <\/TD>  <\/TD>  <\/TD>  <\/TD>  <\/TD>  <\/TD>  <\/TD>  <\/TD> \n\t

Success<\/font><\/TD> <\/TR>\n

\n\t

9:55:40PM<\/font><\/TD>

\n\t

GERMANY<\/font><\/TD>

\n\t

13149<\/font><\/TD>

 <\/TD>  <\/TD>  <\/TD>  <\/TD>  <\/TD>  <\/TD>  <\/TD>  <\/TD> \n\t

<\/TD> <\/TR>\n

\n\t

10:02:42PM<\/font><\/TD>

\n\t

US500<\/font><\/TD>

\n\t

3074.42<\/font><\/TD>

 <\/TD>  <\/TD>  <\/TD>  <\/TD>  <\/TD>  <\/TD>  <\/TD>  <\/TD> \n\t

<\/TD> <\/TR>\n

\n\t

10:16:58PM<\/font><\/TD>

\n\t

DOW<\/font><\/TD>

\n\t

27491.5<\/font><\/TD>

 <\/TD>  <\/TD>  <\/TD>  <\/TD>  <\/TD>  <\/TD>  <\/TD>  <\/TD> \n\t

<\/TD> <\/TR>\n

\n\t

10:19:23PM<\/font><\/TD>

\n\t

NASDAQ<\/font><\/TD>

\n\t

8206.94<\/font><\/TD>

\n\t

8186<\/font><\/TD>

\n\t

8167<\/font><\/TD>

\n\t

8141<\/font><\/TD>

\n\t

8237<\/font><\/TD>

\n\t

8228<\/font><\/TD>

\n\t

8239.5<\/font><\/TD>

\n\t

8351<\/font><\/TD>

\n\t

8188<\/font><\/TD>

\n\t

‘cess<\/font><\/TD> <\/TR>\n

\n\t

10:22:36PM<\/font><\/TD>

\n\t

JAPAN<\/font><\/TD>

\n\t

23335<\/font><\/TD>

 <\/TD>  <\/TD>  <\/TD>  <\/TD>  <\/TD>  <\/TD>  <\/TD>  <\/TD> \n\t

Success<\/font><\/TD> <\/TR>\n\n<\/TABLE>\n\n

 <\/p>\n

5\/11\/2019 FTSE Closed at 7388 points. Change of 0.26%. Total value traded through LSE was: \u00a3 6,164,114,046 a change of 25.79%<\/h><\/p>\n
4\/11\/2019 FTSE Closed at 7369 points. Change of 0.92%. Total value traded through LSE was: \u00a3 4,900,286,853 a change of -8.27%<\/h><\/p>\n
1\/11\/2019 FTSE Closed at 7302 points. Change of 0.75%. Total value traded through LSE was: \u00a3 5,342,127,869 a change of -12.99%<\/h><\/p>\n
31\/10\/2019 FTSE Closed at 7248 points. Change of -1.12%. Total value traded through LSE was: \u00a3 6,139,753,782 a change of 11.95%<\/h><\/p>\n
30\/10\/2019 FTSE Closed at 7330 points. Change of 0.33%. Total value traded through LSE was: \u00a3 5,484,235,986 a change of 6.15%<\/h><\/p>\n
29\/10\/2019 FTSE Closed at 7306 points. Change of -0.34%. Total value traded through LSE was: \u00a3 5,166,736,018 a change of 9.98%<\/h><\/p>\n
28\/10\/2019 FTSE Closed at 7331 points. Change of 0.1%. Total value traded through LSE was: \u00a3 4,697,887,789 a change of 4.65%<\/h><\/p>\n\n\n","protected":false},"excerpt":{"rendered":"

#BRENT #NASDAQ When we last reviewed Faron, we promoted a scenario for a 25% rise (link). The move successfully happened in May and in the period since, it has more than doubled! Thankfully someone emailed to remind us this was urgently due a Big Picture update. This one is extremely difficult to map thanks to … <\/p>\n

Continue reading “Faron Pharma. for 6\/11\/2019”<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1327","post","type-post","status-publish","format-standard","hentry","category-trendsandtargets"],"_links":{"self":[{"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/posts\/1327","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/comments?post=1327"}],"version-history":[{"count":1,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/posts\/1327\/revisions"}],"predecessor-version":[{"id":1328,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/posts\/1327\/revisions\/1328"}],"wp:attachment":[{"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/media?parent=1327"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/categories?post=1327"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.trendsandtargets.com\/index.php\/wp-json\/wp\/v2\/tags?post=1327"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}